SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19

Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19

NCT04347239 ·Status: COMPLETED ·Phase: PHASE2

ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19

NCT04604184 ·Status: TERMINATED ·Phase: PHASE2

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

NCT04871815 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

NCT06016088 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.

NCT04348383 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia

NCT04738136 ·Status: SUSPENDED ·Phase: PHASE2

Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations

NCT05292053 ·Status: COMPLETED ·Phase: PHASE4

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

NCT04389671 ·Status: COMPLETED ·Phase: PHASE2

A Study of Auxora in Patients With Critical COVID-19 Pneumonia

NCT04661540 ·Status: TERMINATED ·Phase: PHASE2

Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

NCT04948203 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

NCT00517998 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

NCT05238675 ·Status: COMPLETED ·Phase: PHASE2

Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia

NCT04341675 ·Status: COMPLETED ·Phase: PHASE2

Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)

NCT05411575 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

NCT06496620 ·Status: RECRUITING ·Phase: PHASE2

COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111

NCT04388826 ·Status: COMPLETED ·Phase: PHASE2

A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure

NCT04574869 ·Status: WITHDRAWN ·Phase: PHASE1

Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection

NCT04526912 ·Status: TERMINATED ·Phase: PHASE1

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

NCT07048262 ·Status: RECRUITING ·Phase: PHASE2

The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19

NCT04798716 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

NCT06325696 ·Status: RECRUITING ·Phase: PHASE2

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

NCT04326036 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

NCT04472494 ·Status: TERMINATED ·Phase: PHASE2

Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664 ·Status: COMPLETED ·Phase: PHASE2